On November 21, 2025, Robert J. More, the Director of Tyra Biosciences (NASDAQ:TYRA), conducted an open-market sale of 246,871 shares, as detailed in the SEC Form 4 filing. The transaction was valued at $20.25 per share. The 1-year performance was calculated using this date as the reference point. For further details, refer to the SEC documentation.
